Medicalsystem Biotechnology Co., Ltd (SHE:300439)

China flag China · Delayed Price · Currency is CNY
8.70
-0.21 (-2.36%)
Jun 8, 2026, 3:04 PM CST
Market Cap3.34B -16.1%
Revenue (ttm)1.54B -5.7%
Net Income66.57M -68.2%
EPS0.17 -68.8%
Shares Out 384.32M
PE Ratio51.47
Forward PEn/a
Dividend0.03 (0.37%)
Ex-Dividend DateJun 11, 2026
Volume3,161,050
Open8.85
Previous Close8.91
Day's Range8.60 - 8.93
52-Week Range8.62 - 12.20
Beta0.26
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:300439

Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly... [Read more]

Sector Healthcare
Founded 2003
Employees 1,936
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300439
Full Company Profile

Financial Performance

In 2025, SHE:300439's revenue was 1.54 billion, a decrease of -11.67% compared to the previous year's 1.74 billion. Earnings were 63.20 million, a decrease of -75.50%.

Financial Statements